Comparison of the QT/QTc Interval Between an Outpatient HIV-Infected Population on Antiretroviral Therapy and Two Large HIV-Negative Cohorts
NCT01824628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 160
Last updated 2013-11-26
Summary
This is a unicentric, two cohorts, observational transversal study.
The purpose of this study is to compare the QT/QTc intervals of HIV positive subjects receiving an antiretroviral therapy and those without HIV in an ambulatory care setting.
Conditions
- QT and Corrected QT Intervals Prolongation in HIV Positive Subjects Treated With an Antiretroviral Regimen
Sponsors & Collaborators
-
Centre hospitalier de l'Université de Montréal (CHUM)
lead OTHER
Principal Investigators
-
Jacques Turgeon, B. Pharm., M. Sc., Ph. D. · Centre de Recherche du Centre Hospitalier de l'Université de Montréal
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2013-03-31
- Primary Completion
- 2013-10-31
- Completion
- 2013-11-30
Countries
- Canada
Study Locations
More Related Trials
-
Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week
NCT04867083 ·Status: UNKNOWN ·Phase: PHASE3
-
A Study of Ritonavir-Boosted Invirase (Saquinavir) in Treatment-Naïve HIV-1 Infected Patients
NCT01638650 ·Status: COMPLETED ·Phase: PHASE1
-
TMC125-C216: A Phase III Study to Investigate the Efficacy, Tolerability and Safety of TMC125 as Part of an Antiretroviral Regimen, Including TMC114/Ritonavir and an Investigator-selected Optimized Background, in HIV-1 Infected Patients With Limited to no Treatment Options.
NCT00255099 ·Status: COMPLETED ·Phase: PHASE3
-
Comparing FTC and Lamivudine in HIV-Infected Patients on a Stable Anti-HIV Drug Combination
NCT00002416 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of DTG/3TC in Treatment-naïve HIV-1 Infected Patients
NCT06928090 ·Status: ENROLLING_BY_INVITATION
-
Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
NCT05295394 ·Status: WITHDRAWN ·Phase: PHASE4
-
Evaluation of the Safety and the Tolerability of a Combination of Two HIV Inducers in Patients With Undetectable Viral Load
NCT05230368 ·Status: COMPLETED ·Phase: PHASE1
-
Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients
NCT00050895 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Tolerability of DTG Plus 3TC in HIV Infected Adults With Virologically Suppression and TDF Toxicity
NCT05493969 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4
-
Effectiveness and Safety of Epivir/Ziagen/Zerit (3TC/ABC/d4T) Versus Epivir/Ziagen/Sustiva (3TC/ABC/EFV) Versus Epivir/Ziagen/Agenerase/Norvir (3TC/ABC/APV/RTV) in HIV Patients Who Have Never Received Treatment
NCT00005017 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (MK0518-018 EXT2)
NCT00293267 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Indinavir Plus Ritonavir Plus Two NRTIs vs. Nelfinavir Plus Two NRTIs in HIV Positive Patients (0639-112)(COMPLETED)
NCT00541463 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study of Elvucitabine in HIV-1 Subjects
NCT00405249 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness and Safety of Two Forms of Stavudine in HIV-Infected Patients
NCT00005918 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Evaluate the Safety and Efficacy of Raltegravir (MK0518) in HIV-Infected Patients Failing Current Antiretroviral Therapies (0518-019)
NCT00293254 ·Status: COMPLETED ·Phase: PHASE3
-
To Investigate the Safety and Efficacy of UB-421 Monotherapy in HIV Infected Adults
NCT02369146 ·Status: COMPLETED ·Phase: PHASE2
-
A Comparison of 141W94 and Indinavir in HIV-Infected Patients
NCT00002202 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase III Randomized Double-Blind, Multicenter Study to Evaluate the Safety and Efficacy of 3TC/ZDV/1592U89 and 3TC/ZDV/IDV in HIV-1 Infected Antiretroviral Therapy-Naive Subjects.
NCT00002199 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Compare Two Anti-HIV Drug Combinations
NCT00002447 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate the Safety and Efficacy of a Single Tablet Regimen of Emtricitabine/Rilpivirine/Tenofovir Disoproxil Fumarate Compared With a Single Tablet Regimen of Efavirenz/Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
NCT01309243 ·Status: COMPLETED ·Phase: PHASE3
-
TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.
NCT00245739 ·Status: APPROVED_FOR_MARKETING
-
Pharmacokinetics, Safety, and Efficacy of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet Regimen (STR) in Adolescents
NCT01721109 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
An Open-label Trial With TMC125 in Patients Who Have Virologically Failed in a DUET Trial (TMC125-C206 or TMC125-C216).
NCT00359021 ·Status: COMPLETED ·Phase: PHASE3
-
A Comparison of Emtricitabine and Abacavir Used in a Three-Drug Combination in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs
NCT00002362 ·Status: SUSPENDED ·Phase: PHASE3
-
Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1 Infected Adolescents
NCT02276612 ·Status: COMPLETED ·Phase: PHASE2/PHASE3